Royalty Pharma (RPRX)
(Real Time Quote from BATS)
$27.74 USD
+0.03 (0.11%)
Updated Sep 25, 2024 12:54 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Industry / Sector Report
Industry : Financial - Miscellaneous Services
Zacks Industry Rank
Top 21% (52 out of 252)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.42 | 1.88 | 9.99 |
Current Quarter Estimate | 0.94 | 9.67 | 61.00 |
Year Ago Quarter Estimate | 0.79 | 10.26 | 54.84 |
Next Quarter Estimate | 1.11 | 8.49 | 63.00 |
Next Year Estimate | 4.36 | 45.79 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -10.02 | 8.20 | 15.67 |
Next Year | 7.92 | 15.40 | 11.34 |
Last 5 Years | NA | 5.50 | 8.10 |
Next 5 Years | 1.70 | 18.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 7.14 | 0.37 |
Price/Book (MRQ) | 1.69 | 1.08 |
Price/Cash Flow (MRFY) | 6.07 | 8.91 |
Dividend Yield | 3.03% | 0.00% |
Net Profit Margin (TTM) | 30.08% | 7.70% |
Return on Equity (TTM) | 23.61% | 9.86% |
Debt to Equity (MRQ) | 0.78 | 28.38 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.